View by Specialty

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

Oncology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
August 31, 2017
2 min read
Save

Higher FIB-4 index in patients with HBV linked to increased HCC risk

In a cohort of patients with chronic hepatitis B without cirrhosis, the risk for hepatocellular carcinoma was significantly higher among those with a FIB-4 index over 1.29, according to recently published data.

SPONSORED CONTENT
August 17, 2017
1 min read
Save

Two liver cancer T-cell therapies receive orphan drug designation

The FDA recently granted two orphan drug designations to Lion TCR for T-cell therapy products for the treatment of hepatocellular carcinoma, according to a press release.

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

SPONSORED CONTENT
August 09, 2017
2 min read
Save

Vaccine program in Alaskan Natives eliminates acute HBV, early HCC

The Liver Disease and Hepatitis Program, which includes universal newborn hepatitis B vaccination and mass screening and immunization, has eliminated acute HBV and early-onset hepatocellular carcinoma as a public health threat among Alaska Native children, according to a study presented at the World Indigenous Peoples’ Conference on Viral Hepatitis.

SPONSORED CONTENT
August 04, 2017
2 min read
Save

Liver cancer, mortality risks decrease with SVR after direct-acting antivirals

Patients who achieved sustained virologic response after direct-acting antiviral treatment also had significantly lower all-cause mortality and lower incident rates of hepatocellular carcinoma compared with patients who did not achieve SVR.

SPONSORED CONTENT
July 26, 2017
1 min read
Save

Eisai submits supplemental new drug application to FDA for Lenvima

Eisai submitted a supplemental new drug application to the FDA to seek approval for lenvatinib as a frontline therapy for patients with hepatocellular carcinoma.

SPONSORED CONTENT
July 24, 2017
2 min read
Save

Occult HBV does not affect HCC resection outcomes

The presence of hepatitis B core antibody, or HBcAb, did not affect the outcomes of hepatic resection in patients with either hepatitis C-related or non-B, non-C hepatocellular carcinoma, according to results of a recent study. However, the data showed a possible link between occult hepatitis B infection and hepatocarcinogenesis in patients with non-B, non-C HCC.

SPONSORED CONTENT
July 17, 2017
2 min read
Save

HCC risk increases in men with HBV, multiple metabolic risk factors

Men aged 40 to 65 years with chronic hepatitis B and a high burden of metabolic risk factors had increased risk for hepatocellular carcinoma, especially is they were smokers, according to a recently published study.

SPONSORED CONTENT
July 17, 2017
6 min read
Save

Targeting MSM with HIV: Treatment as Prevention in the Netherlands

Targeting MSM with HIV: Treatment as Prevention in the Netherlands

The Dutch government has been taking comprehensive steps to deal with HCV. In November 2015, they ruled to treat all patients with HCV, regardless of age, cirrhosis or fibrosis status, risk profile, injection drug use status or sexual orientation. As part of the national HIV guidelines, all individuals with HIV are screened for hepatitis C. The strategies go hand-in-hand, with one overarching aim: treatment as prevention. The goal is to stop transmission of HCV cold. Because men who have sex with men (MSM) with HIV are at the highest risk for transmitting the disease, they placed particular emphasis on testing and treating that population.

SPONSORED CONTENT
July 14, 2017
2 min read
Save

Low lymphocyte infiltration in HCC linked to recurrence, poor OS

Recently published data revealed a significant association between low lymphocyte infiltration in hepatocellular carcinoma tumors and higher recurrence rates and poor overall survival compared with high lymphocyte infiltration.

SPONSORED CONTENT
July 10, 2017
5 min read
Save

Drinking coffee reduces risk for death

Among people of various ethnicities and cultures, higher coffee consumption — whether caffeinated or decaffeinated — was associated with all-cause and cause-specific mortality benefits, according to two new studies published in Annals of Internal Medicine.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails